EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort from Two Chilean Cities, 2020–2022

Loreto Núñez-Franz, Muriel Ramírez-Santana iD, Paola Rubilar iD, Cecilia Vial iD, Mauricio Apablaza, Claudia González, Macarena Said, Kathya Olivares, Lina Jimena Cortés iD, Juan Hormazábal iD, Luis Canales iD, Pablo Vial und 3 weitere

Viruses · 2023

DOI: 10.3390/v15010201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Loreto Núñez-Franz und 14 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Salud Pública, Facultad de Ciencias de la Salud, Universidad de Talca, Talca 3460000, Chile. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chilean National Research Agency, WHO Unity Studies, COVID-19 Solidarity Response Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chile has achieved the highest coverage for vaccines against the SARS-CoV-2 virus worldwide.

Objective

To assess the progression of immunity (natural and acquired by vaccine) in a cohort from two Chilean cities.

Methods

Individuals (n = 386) who participated in three phases of population-based serial prevalence studies were included (2020–2021 and 2022). Presence of SARS-CoV-2 antibodies was measured in serum. Data including time of vaccination and type of vaccine received were analysed with descriptive statistics.

Results

Seroprevalence was 3.6% in the first round and increased to 96.9% in the second and 98.7% in the third. In the third round, 75% of individuals who had received the basal full scheme were seropositive at 180 days or more since their last dose; 98% of individuals who received one booster dose were seropositive at 180 days or more, and 100% participants who received two boosters were seropositive, regardless of time since their last dose. Participants receiving mRNA vaccines had higher seroprevalence rates over time.

Conclusions

The high vaccination coverage in Chile enabled the population to maintain high levels of antibodies. Vaccination boosters are essential to maintain immunity over time, which also depends on the type of vaccine administered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansChileCitiesSeroepidemiologic StudiesAdaptive ImmunityAntibodies, Viral

Stichwörter der Autor:innen

COVID-19Chileantibodiesimmunityseroepidemiologyseroprevalencevaccines

Substanzen

Antibodies, Viral

Autor:innen und Institutionen

  • Departamento de Salud Pública, Facultad de Ciencias de la Salud, Universidad de Talca, Talca 3460000, Chile.
  • Public Health Department, Faculty of Medicine, Universidad Católica del Norte, Coquimbo 1780000, Chile.
  • Centro de Epidemiología y Políticas de Salud, Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago 7550000, Chile.
  • Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago 8320000, Chile.
  • Facultad de Gobierno, Universidad del Desarrollo, Santiago 7550000, Chile.
  • Facultad de Economía y Negocios, Universidad de Talca, Talca 3460000, Chile.

ORCID-Profile: Muriel Ramírez-Santana, Paola Rubilar, Cecilia Vial, Lina Jimena Cortés, Juan Hormazábal, Luis Canales, Ximena Aguilera

Förderung

  • Chilean National Research Agency
  • WHO Unity Studies
  • COVID-19 Solidarity Response Fund
  • German Federal Ministry of Health (BMG) COVID-19 Research and Development Fund

Zitieren

APA

Núñez-Franz, L., Ramírez-Santana, M., Rubilar, P., Vial, C., Apablaza, M., González, C., Said, M., Olivares, K., Cortés, L. J., Hormazábal, J., Canales, L., Vial, P., Icaza, G., Quezada-Gaete, R., & Aguilera, X. (2023). Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort from Two Chilean Cities, 2020–2022. Viruses. https://doi.org/10.3390/v15010201

Vancouver

Núñez-Franz L, Ramírez-Santana M, Rubilar P, Vial C, Apablaza M, González C, et al. Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort from Two Chilean Cities, 2020–2022. Viruses. 2023. doi:10.3390/v15010201

BibTeX
@article{NezFranz2023,
  author = {Núñez-Franz, Loreto and Ramírez-Santana, Muriel and Rubilar, Paola and Vial, Cecilia and Apablaza, Mauricio and González, Claudia and Said, Macarena and Olivares, Kathya and Cortés, Lina Jimena and Hormazábal, Juan and Canales, Luis and Vial, Pablo and Icaza, Gloria and Quezada-Gaete, Rubén and Aguilera, Ximena},
  title = {Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort from Two Chilean Cities, 2020–2022},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15010201}
}
Kostenlos starten →